Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

  1. Colagrossi, L.
  2. Hermans, L.E.
  3. Salpini, R.
  4. Di Carlo, D.
  5. Pas, S.D.
  6. Alvarez, M.
  7. Ben-Ari, Z.
  8. Boland, G.
  9. Bruzzone, B.
  10. Coppola, N.
  11. Seguin-Devaux, C.
  12. Dyda, T.
  13. Garcia, F.
  14. Kaiser, R.
  15. Köse, S.
  16. Krarup, H.
  17. Lazarevic, I.
  18. Lunar, M.M.
  19. Maylin, S.
  20. Micheli, V.
  21. Mor, O.
  22. Paraschiv, S.
  23. Paraskevis, D.
  24. Poljak, M.
  25. Puchhammer-Stöckl, E.
  26. Simon, F.
  27. Stanojevic, M.
  28. Stene-Johansen, K.
  29. Tihic, N.
  30. Trimoulet, P.
  31. Verheyen, J.
  32. Vince, A.
  33. Lepej, S.Z.
  34. Weis, N.
  35. Yalcinkaya, T.
  36. Boucher, C.A.B.
  37. Wensing, A.M.J.
  38. Perno, C.F.
  39. Svicher, V.
  40. Show all authors +
Journal:
BMC Infectious Diseases

ISSN: 1471-2334

Year of publication: 2018

Volume: 18

Issue: 1

Type: Article

DOI: 10.1186/S12879-018-3161-2 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus